TickerFacts.

Polaryx Therapeutics, Inc. (PLYX): Shareholders' Equity

Annual figures by period end, from SEC filings.

$4.57M
As of 2025-12-31
$10.94M
As of 2026-06-30
$4.71M2024-12-31: $4.71M2025-12-31: $4.57M$4.57M
2024-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$4.57M-3.1%2026-03-24, Balance as of period end
2024-12-31$4.71Mn/a2026-03-24, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Polaryx Therapeutics, Inc. (PLYX)2025-12-31$4.57M-3.1%
Petros Pharmaceuticals, Inc. (PTPI)2025-12-31$2.87Mn/m
Enveric Biosciences, Inc. (ENVB)2025-12-31$4.18M+162.3%
Azitra, Inc. (AZTR)2025-12-31$3.80M-33.3%
Quantum Cyber N.V. (QUCY)2025-12-31$641.6K-89.3%
60 Degrees Pharmaceuticals, Inc. (SXTP)2025-12-31$3.46M-14.2%
International Stem Cell Corp (ISCO)2025-12-31-$4.06Mn/m
AEON Biopharma, Inc. (AEON)2025-12-31-$55.03Mn/m
Jupiter Neurosciences, Inc. (JUNS)2025-12-31-$1.83Mn/m

Compare PLYX, PTPI, ENVB, AZTR side by side · Screen every company in Pharmaceutical Preparations ↗